A new coverage determination will prevent Medicare patients with certain cancers from accessing genetic testing, a move that advocates and testing companies say will severely limit early interventions ...

Biotheranostics, a subsidiary of San Diego-based Hologic, has received expanded Medicare coverage of its Breast Cancer Index test. The additional coverage became effective May 10, according to CMS.

CMS is the single largest payer for healthcare in the United States, with Medicare responsible for approximately 21% of total healthcare ...

In July, the Centers for Medicare and Medicaid Services (CMS) announced a six-year test of more aggressive prior authorization in Medicare’s traditional fee-for-service (FFS) program. CMS will conduct ...

During an ICD-10 testing week in March, CMS accepted 89 percent of the more than 127,000 test ICD-10 claims sent to the agency’s Medicare fee-for-service system. All testers received an ...

Six states will be testing a new model, developed by the Centers for Medicare and Medicaid Services (CMS), for the federal health program Medicare in 2026. At the end of June, CMS announced the new ...